(Reuters)-New Zealand dairy giant Fonterra signed partnership with U.S.-based biotechnology company VitaKey on Thursday to explore ways to use probiotic strains to extend product freshness and nutrients. He said.
Fonterra said in a statement that it is considering designing dairy products that contain time-controlled releases of nutrients in certain dairy products. The financial terms of the partnership have not been disclosed.
Cooperation has been signed as global supply chain disruptions have highlighted the need to extend product shelf life while maintaining nutrition. The coronavirus pandemic also raises concerns about a healthy diet as people around the world adapt to lifestyles, including long-term work and staying at home.
Judith Wales, Fonterra’s Chief Executive Officer for the Asia Pacific region, said:
“Nutrients are encapsulated and targeted, so we can use less milk for production and more milk while reducing food waste,” says Swales. ..
VitaKey’s nutrient platform is licensed from the Massachusetts Institute of Technology and is based on technology developed at Langer Labs.
Fusion media Alternatively, anyone involved in Fusion Media will not be liable for any loss or damage resulting from relying on the data, quotes, charts, trading signals and other information contained on this website. Please be fully informed about the risks and costs associated with financial market transactions. This is one of the most risky forms of investment possible.
New Zealand dairy giant Fonterra signs partnership with US biotechnology company VitaKeyByReuters
https://www.investing.com/news/stock-market-news/nz-dairy-giant-fonterra-seals-partnership-deal-with-us-biotech-firm-vitakey-2667224 New Zealand dairy giant Fonterra signs partnership with US biotechnology company VitaKeyByReuters